Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 19

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 12
Chunk 19
---
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The following table also sets forth information known to us regarding the beneficial ownership of our common stock as of March 3, 2025:

•        each person who is, or is expected to be, the beneficial owner of more than 5% of the outstanding shares of our common stock;

•        each of our current officers and directors; and

•        all current executive officers and directors of the Company, as a group.

 81

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants are deemed to be outstanding for purposes of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding for purposes of computing the beneficial ownership percentage of any other person.

The beneficial ownership of our common stock is based on 905,228 shares of common stock issued and outstanding as of March 3, 2025.

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock owned by them.

    Name
     
    Number of Shares Beneficially Owned
     
    Beneficial Ownership (%)

    Directors and Officers of Revelation(1):

    James Rolke(2)
     
    30,142

    3.2
    % 

    George F. Tidmarsh M.D., Ph.D.(3)
     
    281

    *

    Jennifer Carver, BSN, MBA(4)
     
    200

    *

    Jess Roper(5)
     
    196

    *

    Lakhmir Chawla, M.D.(6)
     
    181

    *

    Chester S. Zygmont, III(7)
     
    15,090

    1.6
    % 

    All Directors and Officers as a Group (Six Individuals)
     
    46,090

    5.0
    % 

____________

*        Less than one percent.

(1)Unless otherwise indicated, the business address of each of the individuals is c/o Revelation Biosciences, Inc., 4660 La Jolla Village Dr., Suite 100